FreeDom: Innovative Strategy for the Management of COPD Exacerbations
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLaval University
About this trial
The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation.
The main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.
Eligibility criteria
Qualifiers
known or suspected COPD to entry
Age > or = 40 years
Ex-smoker history (10 pack / year or more)
Acute Exacerbation: dyspnea of recent onset (less than 15 days)
Disqualifiers
Refusal to consent to participate in the study,
Indication for an imminent intubation according to the pulmonologist,
Sleep Apnea
NIV used at home
Trial design
Treatments tested in this trial
- Control
- FreeDom
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov